Dextech Medical AB (NGM:DEX)
4.100
-0.060 (-1.44%)
At close: Feb 26, 2025
Dextech Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 16.32 | 19.04 | 25.24 | 35.47 | 3.46 | 6.09 | Upgrade
|
Cash & Short-Term Investments | 16.32 | 19.04 | 25.24 | 35.47 | 3.46 | 6.09 | Upgrade
|
Cash Growth | -26.35% | -24.54% | -28.86% | 926.20% | -43.25% | 53887.79% | Upgrade
|
Other Receivables | - | 0.13 | 0.11 | 0.2 | 0.03 | 0.03 | Upgrade
|
Receivables | 0.37 | 0.13 | 0.11 | 0.2 | 0.03 | 0.03 | Upgrade
|
Other Current Assets | - | 0.5 | 0.47 | 0.35 | 0.26 | 0.25 | Upgrade
|
Total Current Assets | 16.69 | 19.68 | 25.82 | 36.02 | 3.75 | 6.37 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Intangible Assets | 11.03 | 0.25 | 0.25 | 0.39 | 0.54 | 0.51 | Upgrade
|
Long-Term Deferred Charges | - | 10.66 | 8.97 | 3.18 | 2.94 | 6.46 | Upgrade
|
Total Assets | 27.72 | 30.59 | 35.03 | 39.59 | 7.23 | 13.34 | Upgrade
|
Accounts Payable | - | 0.28 | 0.15 | 0.25 | 0.04 | 0.07 | Upgrade
|
Accrued Expenses | - | 0.69 | 0.55 | 0.43 | 0.15 | 0.15 | Upgrade
|
Other Current Liabilities | 0.21 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | Upgrade
|
Total Current Liabilities | 0.21 | 0.98 | 0.72 | 0.71 | 0.22 | 0.25 | Upgrade
|
Total Liabilities | 0.21 | 0.98 | 0.72 | 0.71 | 0.22 | 0.25 | Upgrade
|
Common Stock | 27.51 | 0.83 | 0.83 | 0.83 | 0.67 | 0.67 | Upgrade
|
Additional Paid-In Capital | - | 105.2 | 105.2 | 105.2 | 68.22 | 68.22 | Upgrade
|
Retained Earnings | - | -76.42 | -71.71 | -67.15 | -61.88 | -55.8 | Upgrade
|
Shareholders' Equity | 27.51 | 29.61 | 34.31 | 38.88 | 7.02 | 13.09 | Upgrade
|
Total Liabilities & Equity | 27.72 | 30.59 | 35.03 | 39.59 | 7.23 | 13.34 | Upgrade
|
Net Cash (Debt) | 16.32 | 19.04 | 25.24 | 35.47 | 3.46 | 6.09 | Upgrade
|
Net Cash Growth | -26.35% | -24.54% | -28.86% | 926.20% | -43.25% | 53887.79% | Upgrade
|
Net Cash Per Share | 0.87 | 1.01 | 1.37 | 2.09 | 0.23 | 0.41 | Upgrade
|
Filing Date Shares Outstanding | 18.49 | 18.49 | 18.49 | 18.49 | 14.92 | 14.92 | Upgrade
|
Total Common Shares Outstanding | 18.49 | 18.49 | 18.49 | 18.49 | 14.92 | 14.92 | Upgrade
|
Working Capital | 16.48 | 18.7 | 25.1 | 35.31 | 3.54 | 6.12 | Upgrade
|
Book Value Per Share | 1.49 | 1.60 | 1.86 | 2.10 | 0.47 | 0.88 | Upgrade
|
Tangible Book Value | 16.48 | 29.36 | 34.07 | 38.49 | 6.47 | 12.58 | Upgrade
|
Tangible Book Value Per Share | 0.89 | 1.59 | 1.84 | 2.08 | 0.43 | 0.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.